← SynDRA
LUBIPROSTONE
SynDRA canonical compound SYN0023421 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | CLCN2 |
| Mechanism of action | chloride channel activator |
| Indication | constipation | irritable bowel syndrome |
| Disease area | gastroenterology |
All known targets
Mechanisms of action (all sources)
- CLCN2 OPENER
- Chloride channel protein 2 opener
- chloride channel activator
- CLCN2 ACTIVATOR
Drug classes
- Chloride Channel Activators
- Chloride Channel Activator
- Chloride Channel Agonists
- Membrane Transport Modulators
ATC classes
- A06A · DRUGS FOR CONSTIPATION
Cross-references
Synonyms
- amitiza
- Lubiprostona
- Lubiprostone hemiketal
- RU-0211
- SPI-0211
- Amitiza
- Lubiprostone [USAN]
- RU0211
- SPI0211
- AMITIZA (TN)
- Amitiza, RU-0211, SPI-0211, Lubiprostone
- (-)-7-((2R,4aR,5R,7aR)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta (b)pyran-5-yl)heptanoic acid
- (-)-7-((2R,4aR,5R,7aR)-2-(1,1-Difluoropentyl)-2-hydroxy-6-oxooctahydrocyclopenta(b)pyran-5-yl)heptanoic acid
- 7-((1R,4R,6R,9R)-4-(1,1-difluoropentyl)-4-hydroxy-8-oxo-5-oxabicyclo(4.3.0)non-9-yl)heptanoic acid
- 7-[(2R,4aR,5R,7aR)-2-(1,1-difluoropentyl)-2-hydroxy-6-oxo-3,4,4a,5,7,7a-hexahydrocyclopenta[b]pyran-5-yl]heptanoic acid
- lubiprostona
- lubiprostonum
- Amitza
- RefChem:55521
- A06AX03
- Lubiprostone (hemiketal)
- MFCD20268389
- Amitiza (TN)
- Bicyclic lubiprostone
- Lubiprostone powder
- NCGC00183105-01
- Lubiprostone (ring open)
- LUBIPROSTONE [MI]
- Lubiprostone (hemiketal)?
- LUBIPROSTONE [INN]
- LUBIPROSTONE [JAN]
- LUBIPROSTONE [VANDF]
- LUBIPROSTONE [MART.]
- LUBIPROSTONE [WHO-DD]
- SCHEMBL217184
- GTPL4242
- Lubiprostone (JAN/USAN/INN)
- orb2564331
Reported adverse events
- Nausea
- Abdominal discomfort
- Abdominal distension
- Abdominal pain
- Chest discomfort
- Dizziness
- Dyspepsia
- Headache
- Vomiting
- Dry mouth
- Fatigue
- Flatulence
Look up LUBIPROSTONE in the interactive SynDRA portal →